Metabolome analysis using cerebrospinal fluid from narcolepsy type 1 patients

Area of Science:

• Neuroscience
• Metabolomics
• Sleep Medicine

Background:

• Narcolepsy type 1 (NT1) is a sleep disorder characterized by excessive daytime sleepiness and cataplexy.
• The pathophysiology of NT1 is not fully understood, but altered fatty acid metabolism is suspected.
• Detailed mechanisms linking metabolism to NT1 remain unclear.

Purpose of the Study:

• To investigate the metabolic profile of cerebrospinal fluid in Narcolepsy type 1 patients.
• To identify specific metabolites associated with NT1 and sleep disturbances.
• To explore potential compensatory metabolic pathways in NT1.

Main Methods:

• Cerebrospinal fluid samples from 14 NT1 patients and 17 controls were analyzed using capillary electrophoresis coupled with Fourier transform mass spectrometry.
• Metabolomic analysis identified 268 metabolites.
• High-performance liquid chromatography (HPLC) was used for validation and histamine level assessment.

Main Results:

• Histidine levels were significantly increased in NT1 patients (p = 4.0 × 10-4).
• Histamine levels were significantly decreased in NT1 patients (p = 6.12 × 10-4).
• 5'-deoxy-5'-methylthioadenosine correlated with the apnea-hypopnea index (p = 2.66 × 10-6), and gamma-aminobutyric acid correlated with REM sleep latency.

Conclusions:

• Altered histidine and histamine metabolism may play a role in Narcolepsy type 1 pathophysiology.
• Enhanced glycogenesis might be a compensatory mechanism for impaired fatty acid metabolism in NT1.
• Specific metabolites like 5'-deoxy-5'-methylthioadenosine and gamma-aminobutyric acid warrant further investigation for their roles in NT1 and sleep regulation.